Psychopharmacologic Approaches to Treatment of
Psychopathology Complete Questions with Verified Correct
Answers & Detailed Rationales | Graded A+ | Updated 2026
QUESTION 1
During gene expression, what must occur prior to a gene being expressed?
A. The gene must be replicated during mitosis
B. A transcription factor must bind to the regulatory region within the cell's
nucleus
C. The messenger RNA must be translated in the cytoplasm
D. The gene must be transported to the ribosome
Rationale: Prior to gene expression, a transcription factor must bind to the
regulatory region within the cell's nucleus. Transcription factors are proteins that
bind to specific DNA sequences, controlling the rate of transcription of genetic
information from DNA to messenger RNA. This is the first and essential step in
gene expression.
QUESTION 2
A noncompliant patient states, "Why do you want me to put this poison in my
body?" What is the PMHNP's best response?
A. "You have to take your medication to become stable."
B. "If you don't take your medication, you will end up back in the hospital."
C. "Most medications used in treatment are either increasing or decreasing
neurotransmitters that your body already has."
D. "Why do you believe that your medication is poison?"
Rationale: The most therapeutic response educates the patient that psychotropic
medications work with the body's existing neurotransmitters, normalizing the
treatment rather than dismissing concerns. This patient-centered, educational
response addresses noncompliance by explaining the rationale for medication in a
non-confrontational, biologically based manner.
,QUESTION 3
The PMHNP is assessing a 29-year-old patient who takes antipsychotics that block
D2 receptors. This patient has begun to develop a common side effect of this
medication. What is this side effect?
A. Akathisia
B. Dystonia
C. Parkinsonism
D. Tardive dyskinesia
Rationale: Dopamine receptor blockade, especially with long-term use, can lead to
tardive dyskinesia, a potentially irreversible movement disorder. Tardive
dyskinesia is characterized by involuntary, repetitive movements of the face,
tongue, and limbs. It is a common side effect of antipsychotic medications that
block D2 receptors, particularly with first-generation antipsychotics.
QUESTION 4
Neurotransmission is unidirectional insofar as chemical and electrical conduction
is concerned within the individual neuron. Which of the following descriptions
accurately describes this process?
A. Neurotransmitters travel in both directions across the synapse
B. Information flows from the dendrites to the cell body to the axon terminal
C. Electrical impulses travel from the axon terminal back to the dendrites
D. Neurotransmission occurs randomly within the neuron
Rationale: Within an individual neuron, neurotransmission is unidirectional.
Information flows from the dendrites (where signals are received), to the cell body
(where signals are integrated), and then to the axon terminal (where
neurotransmitters are released). This directionality is fundamental to neuronal
communication.
QUESTION 5
,Though medications have the ability to target neurotransmitter release into the
synapse by the presynaptic neuron, it is not always necessary. The PMHNP
understands that this is because:
A. Medications can bypass the synaptic cleft entirely
B. The postsynaptic neuron can produce its own neurotransmitters
C. Neurotransmitters can spread by diffusion
D. Reuptake is not required for neurotransmission
Rationale: Neurotransmitters can spread by diffusion across the synaptic cleft,
allowing them to reach receptors on the postsynaptic neuron without requiring
direct targeting by medications. This diffusion is a natural mechanism of
neurotransmission.
QUESTION 6
Which amino acid is involved in the synthesis of both norepinephrine and
dopamine?
A. Tryptophan
B. Glutamate
C. Tyrosine
D. GABA
Rationale: Tyrosine is the precursor amino acid for the synthesis of dopamine,
norepinephrine, and epinephrine. The pathway proceeds as follows: Tyrosine → L-
DOPA → Dopamine → Norepinephrine → Epinephrine. This is a critical pathway
in catecholamine synthesis.
QUESTION 7
As it relates to G-protein linked receptors, what does the PMHNP understand about
medications that are used in practice?
A. G-protein linked receptors are only found in the peripheral nervous system
B. G-protein linked receptors mediate slow, prolonged responses through
second messenger systems
C. Medications cannot target G-protein linked receptors
D. G-protein linked receptors only respond to hormones
, Rationale: G-protein linked receptors mediate slow, prolonged responses through
second messenger systems such as cyclic AMP and phosphoinositide pathways.
Many psychotropic medications target these receptors, including certain
antidepressants and antipsychotics.
QUESTION 8
What is the primary mechanism by which selective serotonin reuptake inhibitors
(SSRIs) exert their therapeutic effect?
A. Blocking serotonin receptors on the postsynaptic neuron
B. Inhibiting the reuptake of serotonin from the synaptic cleft
C. Increasing the synthesis of serotonin
D. Activating serotonin autoreceptors
Rationale: SSRIs primarily exert their therapeutic effect by inhibiting the reuptake
of serotonin from the synaptic cleft back into the presynaptic neuron. This
increases the concentration of serotonin available to bind to postsynaptic receptors,
enhancing serotonergic neurotransmission.
QUESTION 9
Which of the following symptoms is NOT characteristic of a manic episode?
A. Grandiosity
B. Decreased need for sleep
C. Pressured speech
D. Low self-esteem
Rationale: Manic episodes are characterized by elevated, expansive, or irritable
mood, grandiosity, decreased need for sleep, pressured speech, racing thoughts,
distractibility, and increased goal-directed activity. Low self-esteem is a symptom
of depression, not mania.
QUESTION 10
What is the strongest established risk factor for bipolar disorder?